Healthcare Supply Chains Need Resilience and Global Integration
Source:PIB ↗
কেন এটি গুরুত্বপূর্ণ
It addresses India's strategic vision for the healthcare, pharmaceutical, and medical device sectors, focusing on supply chain resilience, self-reliance (Atmanirbhar Bharat), and global export competitiveness.
সারসংক্ষেপ
At the Bharat Health Global Expo 2026, Commerce and Industry Minister Shri Piyush Goyal called for building resilient, globally integrated healthcare and pharmaceutical supply chains, emphasizing domestic manufacturing, quality assurance, and making India a trusted global healthcare partner.
মূল বিষয়
- Commerce and Industry Minister Shri Piyush Goyal emphasized the need for India to build resilient, globally integrated healthcare supply chains at the Bharat Health Global Expo 2026.
- Stressed positioning India as a reliable global pharmacy and medical hub by ensuring quality, affordability, and accessibility of healthcare products.
- Highlighted the importance of domestic manufacturing of medical devices, pharmaceuticals, and reducing import dependencies through strategic integration with global markets.
গুরুত্বপূর্ণ শব্দ
Bharat Health Global Expo 2026
An international exhibition bringing together the global healthcare and pharmaceutical value chain to showcase innovation, manufacturing capabilities, and strategic partnerships.
UPSC context
UPSC Prelims/Mains: Relevant for government initiatives, international trade, and India's position as a global pharmaceutical hub.
Ministry of Commerce and Industry
The Union government ministry responsible for formulating and implementing trade policies, industrial growth, and commercial regulations in India.
UPSC context
UPSC Prelims/Mains: Core administrative body under GS Paper II (Govt policies) and GS Paper III (Industrial growth and international trade).
প্রিলিমস ফাঁদ
India's status as the 'pharmacy of the world' means it produces all its raw active pharmaceutical ingredients domestically.
India is often assumed to be entirely self-sufficient in pharmaceuticals, but it historically depends on imports for key starting materials (KSMs) and APIs from single-source nations.
সংযুক্ত স্থির ধারণা
What are the strategic policy instruments used by India to boost domestic pharmaceutical and medical device manufacturing?
- PLI Schemes: Production Linked Incentive (PLI) schemes target critical APIs, KSMs, and medical devices to reduce import dependence.
- Bulk Drug Parks: Dedicated bulk drug parks and medical device parks provide plug-and-play common infrastructure to lower capital costs.
- Regulatory Quality: Strengthening regulatory oversight through the Central Drugs Standard Control Organization (CDSCO) to ensure global quality compliance.
আন্তঃবিষয় প্যাটার্ন
Pharmaceutical Supply Chains & WTO TRIPS
India's push for domestic API manufacturing directly intersects with WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) flexibilities and public health exemptions.
Healthcare Autonomy & Indo-Pacific Geopolitics
Reducing import dependencies in critical medical inputs ties industrial self-reliance closely with Indo-Pacific supply chain resilience initiatives.
Expect a statement-based question linking domestic API self-reliance (PLI schemes) with India's 'Pharmacy of the World' positioning.
সংযুক্ত PYQ · 2
সংযুক্ত PYQ · 2
- 2025MainsGS3
Elaborate the scope and significance of supply chain management of agricultural commodities in India.
- 2019MainsGS3
How is the Government of India protecting traditional knowledge of medicine from patenting by pharmaceutical companies?
